Jose P. Garcia, MD, is a board-certified cardiac surgeon at Mass General, and a member of the Corrigan Minehan Heart Center and the Transplant Center. He specializes in heart/lung transplants and is an instructor of surgery at Harvard Medical School.
BiographyJose P. Garcia, MD, graduated with honors from the University of Texas at Austin and received his Medical Degree from Harvard Medical School. After extensive training at both Brigham and Women's Hospital and Boston Children's Hospital he joined Mass General in 2012 where he specializes in heart and lung transplants and mechanical circulatory support including extracorporeal membrane oxygenation (ECMO).
Since completing training at Brigham and Women's Hospital, the focus of Dr. Garcia's career has been on the surgical treatment of heart failure. During his tenure at Temple University Hospital, he performed more than 100 heart transplants and 100 ventricular assist device implantations. At Montefiore Hospital, Dr. Garcia initiated a heart transplant and ventricular assist device program that remains active and successful to date. At the University of Maryland, Dr. Garcia improved heart transplant outcomes for one-year survival to over 90%. Also, the volume of the lung transplant program nearly doubled, largely attributable to the use of ECMO as a bridge to transplant, ex-vivo lung perfusion, and DCD (donor after cardiac death) donors.
He has made several innovative advancements in the application of ECMO as a bridge to transplantation and recovery, including ambulatory ECMO, and the use of ECMO with an atrial septostomy. Additionally, he has been involved in ex-vivo lung perfusion for lung transplantation, and was on the team that performed the first transplant in the US using this technology.
Dr. Garcia is the surgical director of the Cardiothoracic Transplantation and Artificial Heart and Lung Program at Mass General, where he regularly leads teams of other surgeons in successful heart and lung transplant surgeries.
ResearchOver the past 14 years, Dr. Garcia has continued to be on the forefront of clinical innovation in end-stage heart disease, and has been involved in almost every major ventricular assist device trial. In recent years, he has expanded his interests to include acute-lung injury and end-stage lung disease.
Experts from the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care present insights and opinions on methods for treating refractory heart failure, genetically determined arrhythmias and atrial fibrillation in an integrated, multispecialty program.
36-year-old Connecticut resident Benard Basant got his life back when he underwent the MGH’s first combined heart-lung transplant surgery.
The MGH has become the first hospital in New England to successfully perform what’s being called a “lung-in-a-box” transplant.
Lacy Neff, a radio broadcaster from West Virginia, recently underwent a heart transplant as part of his treatment plan for amyloidosis, a rare disease that occurs when amyloid proteins accumulate in the organs. The MGH is one of only seven hospitals in the United States studying cardiac amyloid transplants – and the only one in the Northeast.
Experts from the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care present their experience and provide a practical guide to clinical decision making for patients with heart failure, pulmonary embolism and cardiogenic stroke.